Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 243

1.

Hypertensive diabetic patients: incidence of cardiovascular and renal outcomes in a historical cohort over 11 years.

Sousa AC, Jardim TV, Costa TO, Magalhães FG, Montelo MPM, Souza WKB, Jardim PCBV, Sousa ALL.

Diabetol Metab Syndr. 2017 Dec 21;9:98. doi: 10.1186/s13098-017-0296-z. eCollection 2017.

2.

Systemic factors related to soluble (pro)renin receptor in plasma of patients with proliferative diabetic retinopathy.

Hase K, Kanda A, Hirose I, Noda K, Ishida S.

PLoS One. 2017 Dec 14;12(12):e0189696. doi: 10.1371/journal.pone.0189696. eCollection 2017.

3.

Association of smoking with prevalence of common diseases and metabolic abnormalities in community-dwelling Japanese individuals.

Ueyama C, Horibe H, Yamase Y, Fujimaki T, Oguri M, Kato K, Yamada Y.

Biomed Rep. 2017 Nov;7(5):429-438. doi: 10.3892/br.2017.991. Epub 2017 Sep 27.

4.

Pre-heparin lipoprotein lipase mass as a potential mediator in the association between adiponectin and HDL-cholesterol in type 2 diabetes.

Maser RE, Lenhard MJ, Pohlig RT, Balagopal PB.

J Clin Transl Endocrinol. 2016 Dec 10;7:7-11. doi: 10.1016/j.jcte.2016.12.002. eCollection 2017 Mar.

5.
6.

Diabetes Mellitus, Microalbuminuria, and Subclinical Cardiac Disease: Identification and Monitoring of Individuals at Risk of Heart Failure.

Swoboda PP, McDiarmid AK, Erhayiem B, Ripley DP, Dobson LE, Garg P, Musa TA, Witte KK, Kearney MT, Barth JH, Ajjan R, Greenwood JP, Plein S.

J Am Heart Assoc. 2017 Jul 17;6(7). pii: e005539. doi: 10.1161/JAHA.117.005539.

7.

Eicosapentaenoic and Docosahexaenoic Acids Attenuate Progression of Albuminuria in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease.

Elajami TK, Alfaddagh A, Lakshminarayan D, Soliman M, Chandnani M, Welty FK.

J Am Heart Assoc. 2017 Jul 14;6(7). pii: e004740. doi: 10.1161/JAHA.116.004740.

8.

Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria.

Zobel EH, von Scholten BJ, Reinhard H, Persson F, Teerlink T, Hansen TW, Parving HH, Jacobsen PK, Rossing P.

Cardiovasc Diabetol. 2017 Jul 11;16(1):88. doi: 10.1186/s12933-017-0569-8.

9.

Cardiovascular disease biomarkers are associated with declining renal function in type 2 diabetes.

Jenks SJ, Conway BR, McLachlan S, Teoh WL, Williamson RM, Webb DJ, Welsh P, Sattar N, Strachan MWJ, Price JF.

Diabetologia. 2017 Aug;60(8):1400-1408. doi: 10.1007/s00125-017-4297-0. Epub 2017 May 20.

10.

Target organ damage and incident type 2 diabetes mellitus: the Strong Heart Study.

de Simone G, Wang W, Best LG, Yeh F, Izzo R, Mancusi C, Roman MJ, Lee ET, Howard BV, Devereux RB.

Cardiovasc Diabetol. 2017 May 12;16(1):64. doi: 10.1186/s12933-017-0542-6.

11.

Effects of valsartan and amlodipine on oxidative stress in type 2 diabetic patients with hypertension: a randomized, multicenter study.

Kim HJ, Han SJ, Kim DJ, Jang HC, Lim S, Choi SH, Kim YH, Shin DH, Kim SH, Kim TH, Ahn YB, Ko SH, Kim NH, Seo JA, Kim HY, Lee KW.

Korean J Intern Med. 2017 May;32(3):497-504. doi: 10.3904/kjim.2015.404. Epub 2016 Dec 30.

12.

Characteristics of diabetic nephropathy patients without diabetic retinopathy: A retrospective observational study.

Li XQ, Zheng X, Chen M, Zhao MH.

Medicine (Baltimore). 2017 May;96(18):e6805. doi: 10.1097/MD.0000000000006805.

13.

Differential Effects of Dapagliflozin on Cardiovascular Risk Factors at Varying Degrees of Renal Function.

Petrykiv S, Sjöström CD, Greasley PJ, Xu J, Persson F, Heerspink HJL.

Clin J Am Soc Nephrol. 2017 May 8;12(5):751-759. doi: 10.2215/CJN.10180916. Epub 2017 Mar 16.

14.

Differences in incidence of diabetic retinopathy between type 1 and 2 diabetes mellitus: a nine-year follow-up study.

Romero-Aroca P, Navarro-Gil R, Valls-Mateu A, Sagarra-Alamo R, Moreno-Ribas A, Soler N.

Br J Ophthalmol. 2017 Oct;101(10):1346-1351. doi: 10.1136/bjophthalmol-2016-310063. Epub 2017 Mar 7.

15.

Higher levels of physical activity are independently associated with a lower incidence of diabetic retinopathy in Japanese patients with type 2 diabetes: A prospective cohort study, Diabetes Distress and Care Registry at Tenri (DDCRT15).

Kuwata H, Okamura S, Hayashino Y, Tsujii S, Ishii H; Diabetes Distress and Care Registry at Tenri Study Group.

PLoS One. 2017 Mar 3;12(3):e0172890. doi: 10.1371/journal.pone.0172890. eCollection 2017.

16.

The role of point-of-care 3-hydroxybutyrate testing in patients with type 2 diabetes undergoing coronary angiography.

Vigili de Kreutzenberg S, Avogaro A.

J Endocrinol Invest. 2017 Jun;40(6):627-634. doi: 10.1007/s40618-017-0615-0. Epub 2017 Feb 11.

17.

Serum Acylcarnitines and Risk of Cardiovascular Death and Acute Myocardial Infarction in Patients With Stable Angina Pectoris.

Strand E, Pedersen ER, Svingen GF, Olsen T, Bjørndal B, Karlsson T, Dierkes J, Njølstad PR, Mellgren G, Tell GS, Berge RK, Svardal A, Nygård O.

J Am Heart Assoc. 2017 Feb 3;6(2). pii: e003620. doi: 10.1161/JAHA.116.003620.

20.

Plasma <i>miR-21</i> expression: an indicator for the severity of Type 2 diabetes with diabetic retinopathy.

Jiang Q, Lyu XM, Yuan Y, Wang L.

Biosci Rep. 2017 Mar 27;37(2). pii: BSR20160589. doi: 10.1042/BSR20160589. Print 2017 Apr 28.

Supplemental Content

Loading ...
Support Center